JP2013532636A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013532636A5 JP2013532636A5 JP2013519865A JP2013519865A JP2013532636A5 JP 2013532636 A5 JP2013532636 A5 JP 2013532636A5 JP 2013519865 A JP2013519865 A JP 2013519865A JP 2013519865 A JP2013519865 A JP 2013519865A JP 2013532636 A5 JP2013532636 A5 JP 2013532636A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound
- group
- tetramethyl
- alkenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims description 68
- 150000001875 compounds Chemical class 0.000 claims description 42
- 125000003342 alkenyl group Chemical group 0.000 claims description 35
- 125000000304 alkynyl group Chemical group 0.000 claims description 34
- 125000001188 haloalkyl group Chemical group 0.000 claims description 31
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 30
- 125000003545 alkoxy group Chemical group 0.000 claims description 28
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 26
- 125000002947 alkylene group Chemical group 0.000 claims description 25
- 229910052739 hydrogen Inorganic materials 0.000 claims description 25
- 239000001257 hydrogen Substances 0.000 claims description 25
- 125000004438 haloalkoxy group Chemical group 0.000 claims description 24
- 229910052757 nitrogen Inorganic materials 0.000 claims description 23
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 12
- 150000002431 hydrogen Chemical class 0.000 claims description 12
- 125000001072 heteroaryl group Chemical group 0.000 claims description 11
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 9
- 229910052799 carbon Inorganic materials 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 125000000623 heterocyclic group Chemical group 0.000 claims description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 6
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 6
- 125000001424 substituent group Chemical group 0.000 claims description 6
- 125000004103 aminoalkyl group Chemical group 0.000 claims description 5
- 125000003118 aryl group Chemical group 0.000 claims description 5
- 125000005188 oxoalkyl group Chemical group 0.000 claims description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 5
- VOPWNXZWBYDODV-UHFFFAOYSA-N Chlorodifluoromethane Chemical compound FC(F)Cl VOPWNXZWBYDODV-UHFFFAOYSA-N 0.000 claims description 4
- 125000004001 thioalkyl group Chemical group 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 238000000034 method Methods 0.000 claims 52
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 claims 18
- 125000005843 halogen group Chemical group 0.000 claims 18
- -1 3-tert-butyl-5- (2,4-dioxo-3,4-dihydropyrimidin-1 (2H) -yl) -2-methoxyphenyl Chemical group 0.000 claims 12
- 239000003446 ligand Substances 0.000 claims 11
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical group [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims 10
- 229910000073 phosphorus hydride Inorganic materials 0.000 claims 9
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 claims 8
- 150000003839 salts Chemical class 0.000 claims 8
- 125000006413 ring segment Chemical group 0.000 claims 7
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims 6
- 229910052763 palladium Inorganic materials 0.000 claims 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 4
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 claims 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical group C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims 4
- 239000012018 catalyst precursor Substances 0.000 claims 4
- NXQGGXCHGDYOHB-UHFFFAOYSA-L cyclopenta-1,4-dien-1-yl(diphenyl)phosphane;dichloropalladium;iron(2+) Chemical compound [Fe+2].Cl[Pd]Cl.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 NXQGGXCHGDYOHB-UHFFFAOYSA-L 0.000 claims 4
- 239000012685 metal catalyst precursor Substances 0.000 claims 4
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 claims 4
- LUYQYZLEHLTPBH-UHFFFAOYSA-N perfluorobutanesulfonyl fluoride Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)S(F)(=O)=O LUYQYZLEHLTPBH-UHFFFAOYSA-N 0.000 claims 4
- 125000005003 perfluorobutyl group Chemical group FC(F)(F)C(F)(F)C(F)(F)C(F)(F)* 0.000 claims 4
- 229910052698 phosphorus Inorganic materials 0.000 claims 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims 4
- 229910052723 transition metal Inorganic materials 0.000 claims 4
- 150000003624 transition metals Chemical class 0.000 claims 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical group [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 3
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims 3
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 3
- YNHIGQDRGKUECZ-UHFFFAOYSA-L bis(triphenylphosphine)palladium(ii) dichloride Chemical compound [Cl-].[Cl-].[Pd+2].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-L 0.000 claims 3
- 150000001721 carbon Chemical group 0.000 claims 3
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- 239000001301 oxygen Substances 0.000 claims 3
- 239000011574 phosphorus Substances 0.000 claims 3
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Substances C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 claims 3
- CYPYTURSJDMMMP-WVCUSYJESA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 CYPYTURSJDMMMP-WVCUSYJESA-N 0.000 claims 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims 2
- HDZUMYQGSZNMMK-UHFFFAOYSA-N 1-[3-tert-butyl-5-(6-hydroxynaphthalen-2-yl)-4-methoxyphenyl]pyrimidine-2,4-dione Chemical compound C1=C(C(C)(C)C)C(OC)=C(C=2C=C3C=CC(O)=CC3=CC=2)C=C1N1C=CC(=O)NC1=O HDZUMYQGSZNMMK-UHFFFAOYSA-N 0.000 claims 2
- TWBPWBPGNQWFSJ-UHFFFAOYSA-N 2-phenylaniline Chemical compound NC1=CC=CC=C1C1=CC=CC=C1 TWBPWBPGNQWFSJ-UHFFFAOYSA-N 0.000 claims 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical group [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 2
- 241000700605 Viruses Species 0.000 claims 2
- 125000003282 alkyl amino group Chemical group 0.000 claims 2
- 125000004414 alkyl thio group Chemical group 0.000 claims 2
- 125000006269 biphenyl-2-yl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C1=C(*)C([H])=C([H])C([H])=C1[H] 0.000 claims 2
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 claims 2
- 229910000024 caesium carbonate Inorganic materials 0.000 claims 2
- XJHCXCQVJFPJIK-UHFFFAOYSA-M caesium fluoride Chemical compound [F-].[Cs+] XJHCXCQVJFPJIK-UHFFFAOYSA-M 0.000 claims 2
- 239000000460 chlorine Substances 0.000 claims 2
- 229910052801 chlorine Inorganic materials 0.000 claims 2
- 125000004663 dialkyl amino group Chemical group 0.000 claims 2
- REWLCYPYZCHYSS-UHFFFAOYSA-N ditert-butyl-[3,6-dimethoxy-2-[2,4,6-tri(propan-2-yl)phenyl]phenyl]phosphane Chemical compound COC1=CC=C(OC)C(C=2C(=CC(=CC=2C(C)C)C(C)C)C(C)C)=C1P(C(C)(C)C)C(C)(C)C REWLCYPYZCHYSS-UHFFFAOYSA-N 0.000 claims 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- UUEVFMOUBSLVJW-UHFFFAOYSA-N oxo-[[1-[2-[2-[2-[4-(oxoazaniumylmethylidene)pyridin-1-yl]ethoxy]ethoxy]ethyl]pyridin-4-ylidene]methyl]azanium;dibromide Chemical compound [Br-].[Br-].C1=CC(=C[NH+]=O)C=CN1CCOCCOCCN1C=CC(=C[NH+]=O)C=C1 UUEVFMOUBSLVJW-UHFFFAOYSA-N 0.000 claims 2
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims 2
- MUJIDPITZJWBSW-UHFFFAOYSA-N palladium(2+) Chemical compound [Pd+2] MUJIDPITZJWBSW-UHFFFAOYSA-N 0.000 claims 2
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 claims 2
- 125000005005 perfluorohexyl group Chemical group FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)* 0.000 claims 2
- 125000005007 perfluorooctyl group Chemical group FC(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)* 0.000 claims 2
- 125000005008 perfluoropentyl group Chemical group FC(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)* 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 229910000027 potassium carbonate Inorganic materials 0.000 claims 2
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 claims 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims 2
- 159000000000 sodium salts Chemical class 0.000 claims 2
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- 239000011593 sulfur Substances 0.000 claims 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 2
- 229940062627 tribasic potassium phosphate Drugs 0.000 claims 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims 2
- BWHDROKFUHTORW-UHFFFAOYSA-N tritert-butylphosphane Chemical compound CC(C)(C)P(C(C)(C)C)C(C)(C)C BWHDROKFUHTORW-UHFFFAOYSA-N 0.000 claims 2
- SHAHPWSYJFYMRX-GDLCADMTSA-N (2S)-2-(4-{[(1R,2S)-2-hydroxycyclopentyl]methyl}phenyl)propanoic acid Chemical compound C1=CC([C@@H](C(O)=O)C)=CC=C1C[C@@H]1[C@@H](O)CCC1 SHAHPWSYJFYMRX-GDLCADMTSA-N 0.000 claims 1
- SNJANQMHRGSHFN-UHFFFAOYSA-N (6-hydroxynaphthalen-2-yl)boronic acid Chemical compound C1=C(O)C=CC2=CC(B(O)O)=CC=C21 SNJANQMHRGSHFN-UHFFFAOYSA-N 0.000 claims 1
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims 1
- MZXJPEIZNZSVJI-UHFFFAOYSA-N 1,3,5,7-tetramethyl-8-[2-[2,4,6-tri(propan-2-yl)phenyl]phenyl]-2,4,6-trioxa-8-phosphatricyclo[3.3.1.13,7]decane Chemical compound CC(C)C1=CC(C(C)C)=CC(C(C)C)=C1C1=CC=CC=C1P1C(O2)(C)CC3(C)OC2(C)CC1(C)O3 MZXJPEIZNZSVJI-UHFFFAOYSA-N 0.000 claims 1
- PGNJOOZGCSPQRV-UHFFFAOYSA-N 1-(3,6-dimethoxy-2-phenylphenyl)-2,2,6,6-tetramethylphosphinan-4-one Chemical compound CC1(C)CC(=O)CC(C)(C)P1C=1C(OC)=CC=C(OC)C=1C1=CC=CC=C1 PGNJOOZGCSPQRV-UHFFFAOYSA-N 0.000 claims 1
- RFAABRLZVLYULW-UHFFFAOYSA-N 1-(3-tert-butyl-5-iodo-4-methoxyphenyl)pyrimidine-2,4-dione Chemical compound C1=C(C(C)(C)C)C(OC)=C(I)C=C1N1C(=O)NC(=O)C=C1 RFAABRLZVLYULW-UHFFFAOYSA-N 0.000 claims 1
- ZQRVJWRZCYVGGH-UHFFFAOYSA-N 1-N,1-N,3-N,3-tetramethyl-2-[2-(7,7,9,9-tetramethyl-1,4-dioxa-8-phosphaspiro[4.5]decan-8-yl)phenyl]cyclohexa-1,5-diene-1,3-diamine Chemical compound CC1(C(=C(C=CC1)N(C)C)C1=C(C=CC=C1)P1C(CC2(OCCO2)CC1(C)C)(C)C)NC ZQRVJWRZCYVGGH-UHFFFAOYSA-N 0.000 claims 1
- GAYAKVCPQXTGEC-UHFFFAOYSA-N 1-[1-(2-methoxynaphthalen-1-yl)naphthalen-2-yl]-2,2,6,6-tetramethylphosphinan-4-one Chemical compound COC1=CC=C2C=CC=CC2=C1C(C1=CC=CC=C1C=C1)=C1P1C(C)(C)CC(=O)CC1(C)C GAYAKVCPQXTGEC-UHFFFAOYSA-N 0.000 claims 1
- UGSGDTDUONOHBC-UHFFFAOYSA-N 1-[2-(2,6-dimethoxyphenyl)phenyl]-2,2,6,6-tetramethylphosphinan-4-one Chemical compound COC1=CC=CC(OC)=C1C1=CC=CC=C1P1C(C)(C)CC(=O)CC1(C)C UGSGDTDUONOHBC-UHFFFAOYSA-N 0.000 claims 1
- UVOMLMYKNXKNID-UHFFFAOYSA-N 1-[2-(3,5-dimethoxyphenyl)phenyl]-2,2,6,6-tetramethylphosphinan-4-one Chemical compound COC1=CC(OC)=CC(C=2C(=CC=CC=2)P2C(CC(=O)CC2(C)C)(C)C)=C1 UVOMLMYKNXKNID-UHFFFAOYSA-N 0.000 claims 1
- KQCPGOHSIJKGRZ-UHFFFAOYSA-N 1-[2-[2,6-bis(dimethylamino)phenyl]phenyl]-2,2,6,6-tetramethylphosphinan-4-one Chemical compound CN(C)C1=CC=CC(N(C)C)=C1C1=CC=CC=C1P1C(C)(C)CC(=O)CC1(C)C KQCPGOHSIJKGRZ-UHFFFAOYSA-N 0.000 claims 1
- YVYONCMFSFSYEF-UHFFFAOYSA-N 1-[3,6-dimethoxy-2-(2,4,6-trimethylphenyl)phenyl]-2,2,6,6-tetramethylphosphinan-4-one Chemical compound COC1=CC=C(OC)C(C=2C(=CC(C)=CC=2C)C)=C1P1C(C)(C)CC(=O)CC1(C)C YVYONCMFSFSYEF-UHFFFAOYSA-N 0.000 claims 1
- ZPLQQRVJHAGFKK-UHFFFAOYSA-N 1-[3,6-dimethoxy-2-[2,4,6-tri(propan-2-yl)phenyl]phenyl]-2,2,6,6-tetramethylphosphinan-4-one Chemical compound COC1=CC=C(OC)C(C=2C(=CC(=CC=2C(C)C)C(C)C)C(C)C)=C1P1C(C)(C)CC(=O)CC1(C)C ZPLQQRVJHAGFKK-UHFFFAOYSA-N 0.000 claims 1
- IOAMQMDZZQRNRY-UHFFFAOYSA-N 1-[4,5-dimethoxy-2-[2,4,6-tri(propan-2-yl)phenyl]phenyl]-2,2,6,6-tetramethylphosphinan-4-one Chemical compound CC(C)C=1C=C(C(C)C)C=C(C(C)C)C=1C=1C=C(OC)C(OC)=CC=1P1C(C)(C)CC(=O)CC1(C)C IOAMQMDZZQRNRY-UHFFFAOYSA-N 0.000 claims 1
- MMLPSBIJCVXDOQ-UHFFFAOYSA-N 2,2,6,6-tetramethyl-1-(1-naphthalen-1-ylnaphthalen-2-yl)phosphinan-4-one Chemical compound CC1(C)CC(=O)CC(C)(C)P1C1=CC=C(C=CC=C2)C2=C1C1=CC=CC2=CC=CC=C12 MMLPSBIJCVXDOQ-UHFFFAOYSA-N 0.000 claims 1
- FMAKALPMQOMXNB-UHFFFAOYSA-N 2,2,6,6-tetramethyl-1-[2,3,4,5-tetramethyl-6-[2,4,6-tri(propan-2-yl)phenyl]phenyl]phosphinane Chemical compound CC(C)C1=CC(C(C)C)=CC(C(C)C)=C1C1=C(C)C(C)=C(C)C(C)=C1P1C(C)(C)CCCC1(C)C FMAKALPMQOMXNB-UHFFFAOYSA-N 0.000 claims 1
- VQGFGOOWWYKEBV-UHFFFAOYSA-N 2,2,6,6-tetramethyl-1-[2-[2,4,6-tri(propan-2-yl)phenyl]phenyl]phosphinane Chemical compound CC(C)C1=CC(C(C)C)=CC(C(C)C)=C1C1=CC=CC=C1P1C(C)(C)CCCC1(C)C VQGFGOOWWYKEBV-UHFFFAOYSA-N 0.000 claims 1
- DFLSMXMLBOFAOU-UHFFFAOYSA-N 2,2,7,7-tetramethyl-1-[2-[2,4,6-tri(propan-2-yl)phenyl]phenyl]phosphepane Chemical compound CC(C)C1=CC(C(C)C)=CC(C(C)C)=C1C1=CC=CC=C1P1C(C)(C)CCCCC1(C)C DFLSMXMLBOFAOU-UHFFFAOYSA-N 0.000 claims 1
- NMTUVHBZOJYGDO-UHFFFAOYSA-N 2,4-dichloro-1,5-diphenylpenta-1,4-dien-3-one Chemical compound C=1C=CC=CC=1C=C(Cl)C(=O)C(Cl)=CC1=CC=CC=C1 NMTUVHBZOJYGDO-UHFFFAOYSA-N 0.000 claims 1
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 claims 1
- HWWJYRLUKFEPNH-UHFFFAOYSA-N 3,3,8,8,10,10-hexamethyl-9-[2-[2,4,6-tri(propan-2-yl)phenyl]phenyl]-1,5-dioxa-9-phosphaspiro[5.5]undecane Chemical compound CC(C)C1=CC(C(C)C)=CC(C(C)C)=C1C1=CC=CC=C1P1C(C)(C)CC2(OCC(C)(C)CO2)CC1(C)C HWWJYRLUKFEPNH-UHFFFAOYSA-N 0.000 claims 1
- JGAPHZUZUVQYFX-UHFFFAOYSA-N 7,7,9,9-tetramethyl-8-(1-naphthalen-1-ylnaphthalen-2-yl)-1,4-dioxa-8-phosphaspiro[4.5]decane Chemical compound C1C(C)(C)P(C=2C(=C3C=CC=CC3=CC=2)C=2C3=CC=CC=C3C=CC=2)C(C)(C)CC21OCCO2 JGAPHZUZUVQYFX-UHFFFAOYSA-N 0.000 claims 1
- SJETXUYSRNALQQ-UHFFFAOYSA-N 7,7,9,9-tetramethyl-8-(2-naphthalen-2-ylphenyl)-1,4-dioxa-8-phosphaspiro[4.5]decane Chemical compound C1C(C)(C)P(C=2C(=CC=CC=2)C=2C=C3C=CC=CC3=CC=2)C(C)(C)CC21OCCO2 SJETXUYSRNALQQ-UHFFFAOYSA-N 0.000 claims 1
- CGISGWMFAVDITH-UHFFFAOYSA-N 7,7,9,9-tetramethyl-8-(2-phenylphenyl)-1,4-dioxa-8-phosphaspiro[4.5]decane Chemical compound C1C(C)(C)P(C=2C(=CC=CC=2)C=2C=CC=CC=2)C(C)(C)CC21OCCO2 CGISGWMFAVDITH-UHFFFAOYSA-N 0.000 claims 1
- ZTRKIGQKJSYYFV-UHFFFAOYSA-N 8,8,10,10-tetramethyl-9-[2-[2,4,6-tri(propan-2-yl)phenyl]phenyl]-1,5-dioxa-9-phosphaspiro[5.5]undecane Chemical compound CC(C)C1=CC(C(C)C)=CC(C(C)C)=C1C1=CC=CC=C1P1C(C)(C)CC2(OCCCO2)CC1(C)C ZTRKIGQKJSYYFV-UHFFFAOYSA-N 0.000 claims 1
- OOLMNAGZZDFMJS-UHFFFAOYSA-N 8-(3,6-dimethoxy-2-phenylphenyl)-7,7,9,9-tetramethyl-1,4-dioxa-8-phosphaspiro[4.5]decane Chemical compound CC1(C)CC2(OCCO2)CC(C)(C)P1C=1C(OC)=CC=C(OC)C=1C1=CC=CC=C1 OOLMNAGZZDFMJS-UHFFFAOYSA-N 0.000 claims 1
- HJUUBFQLUARMGK-UHFFFAOYSA-N 8-[1-(2-methoxynaphthalen-1-yl)naphthalen-2-yl]-7,7,9,9-tetramethyl-1,4-dioxa-8-phosphaspiro[4.5]decane Chemical compound COC1=CC=C2C=CC=CC2=C1C(C1=CC=CC=C1C=C1)=C1P(C(C1)(C)C)C(C)(C)CC21OCCO2 HJUUBFQLUARMGK-UHFFFAOYSA-N 0.000 claims 1
- JVIMKUKQYDLAGZ-UHFFFAOYSA-N 8-[2-(2,6-dimethoxyphenyl)phenyl]-7,7,9,9-tetramethyl-1,4-dioxa-8-phosphaspiro[4.5]decane Chemical compound COC1=CC=CC(OC)=C1C1=CC=CC=C1P1C(C)(C)CC2(OCCO2)CC1(C)C JVIMKUKQYDLAGZ-UHFFFAOYSA-N 0.000 claims 1
- BCUFUJDGRRXSNZ-UHFFFAOYSA-N 8-[2-[2,6-di(propan-2-yloxy)phenyl]phenyl]-7,7,9,9-tetramethyl-1,4-dioxa-8-phosphaspiro[4.5]decane Chemical compound CC(C)OC1=CC=CC(OC(C)C)=C1C1=CC=CC=C1P1C(C)(C)CC2(OCCO2)CC1(C)C BCUFUJDGRRXSNZ-UHFFFAOYSA-N 0.000 claims 1
- JVPGPZPKJURROF-UHFFFAOYSA-N 8-[3,6-dimethoxy-2-(2,4,6-trimethylphenyl)phenyl]-7,7,9,9-tetramethyl-1,4-dioxa-8-phosphaspiro[4.5]decane Chemical compound COC1=CC=C(OC)C(C=2C(=CC(C)=CC=2C)C)=C1P(C(C1)(C)C)C(C)(C)CC21OCCO2 JVPGPZPKJURROF-UHFFFAOYSA-N 0.000 claims 1
- BYFHGEFWDTYSSA-UHFFFAOYSA-N 8-[3,6-dimethoxy-2-[2,4,6-tri(propan-2-yl)phenyl]phenyl]-7,7,9,9-tetramethyl-1,4-dioxa-8-phosphaspiro[4.5]decane Chemical compound COC1=CC=C(OC)C(C=2C(=CC(=CC=2C(C)C)C(C)C)C(C)C)=C1P(C(C1)(C)C)C(C)(C)CC21OCCO2 BYFHGEFWDTYSSA-UHFFFAOYSA-N 0.000 claims 1
- AVVSJWUWBATQBX-UHFFFAOYSA-N 97739-46-3 Chemical compound O1C(C)(O2)CC3(C)OC2(C)CC1(C)P3C1=CC=CC=C1 AVVSJWUWBATQBX-UHFFFAOYSA-N 0.000 claims 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 1
- VJJDEWQIDAWYPS-UHFFFAOYSA-N C(C)(C)(C)P(C1=C(C2=CC=CC=C2C=C1)C1=C(C=CC2=CC=CC=C12)C(C)C)C(C)(C)C Chemical compound C(C)(C)(C)P(C1=C(C2=CC=CC=C2C=C1)C1=C(C=CC2=CC=CC=C12)C(C)C)C(C)(C)C VJJDEWQIDAWYPS-UHFFFAOYSA-N 0.000 claims 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 claims 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 claims 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 1
- 229940124683 HCV polymerase inhibitor Drugs 0.000 claims 1
- 102000014150 Interferons Human genes 0.000 claims 1
- 108010050904 Interferons Proteins 0.000 claims 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims 1
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 claims 1
- 229910021605 Palladium(II) bromide Inorganic materials 0.000 claims 1
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 claims 1
- 239000007983 Tris buffer Substances 0.000 claims 1
- RBYGDVHOECIAFC-UHFFFAOYSA-L acetonitrile;palladium(2+);dichloride Chemical compound [Cl-].[Cl-].[Pd+2].CC#N.CC#N RBYGDVHOECIAFC-UHFFFAOYSA-L 0.000 claims 1
- 125000004450 alkenylene group Chemical group 0.000 claims 1
- 125000005037 alkyl phenyl group Chemical group 0.000 claims 1
- 125000004419 alkynylene group Chemical group 0.000 claims 1
- 239000002259 anti human immunodeficiency virus agent Substances 0.000 claims 1
- 125000003710 aryl alkyl group Chemical group 0.000 claims 1
- 125000002618 bicyclic heterocycle group Chemical group 0.000 claims 1
- MUALRAIOVNYAIW-UHFFFAOYSA-N binap Chemical group C1=CC=CC=C1P(C=1C(=C2C=CC=CC2=CC=1)C=1C2=CC=CC=C2C=CC=1P(C=1C=CC=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 MUALRAIOVNYAIW-UHFFFAOYSA-N 0.000 claims 1
- 125000005621 boronate group Chemical group 0.000 claims 1
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 claims 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 1
- 229910052794 bromium Inorganic materials 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 239000000039 congener Substances 0.000 claims 1
- 125000000000 cycloalkoxy group Chemical group 0.000 claims 1
- ZBCKWHYWPLHBOK-UHFFFAOYSA-N cyclohexylphosphane Chemical compound PC1CCCCC1 ZBCKWHYWPLHBOK-UHFFFAOYSA-N 0.000 claims 1
- LCSNDSFWVKMJCT-UHFFFAOYSA-N dicyclohexyl-(2-phenylphenyl)phosphane Chemical compound C1CCCCC1P(C=1C(=CC=CC=1)C=1C=CC=CC=1)C1CCCCC1 LCSNDSFWVKMJCT-UHFFFAOYSA-N 0.000 claims 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- RCRYEYMHBHPZQD-UHFFFAOYSA-N ditert-butyl-[2,3,4,5-tetramethyl-6-[2,4,6-tri(propan-2-yl)phenyl]phenyl]phosphane Chemical compound CC(C)C1=CC(C(C)C)=CC(C(C)C)=C1C1=C(C)C(C)=C(C)C(C)=C1P(C(C)(C)C)C(C)(C)C RCRYEYMHBHPZQD-UHFFFAOYSA-N 0.000 claims 1
- SACNIGZYDTUHKB-UHFFFAOYSA-N ditert-butyl-[2-[2,4,6-tri(propan-2-yl)phenyl]phenyl]phosphane Chemical compound CC(C)C1=CC(C(C)C)=CC(C(C)C)=C1C1=CC=CC=C1P(C(C)(C)C)C(C)(C)C SACNIGZYDTUHKB-UHFFFAOYSA-N 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 239000011737 fluorine Substances 0.000 claims 1
- 125000003709 fluoroalkyl group Chemical group 0.000 claims 1
- 125000005347 halocycloalkyl group Chemical group 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 125000005113 hydroxyalkoxy group Chemical group 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 229940047124 interferons Drugs 0.000 claims 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims 1
- YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 claims 1
- HNQIVZYLYMDVSB-UHFFFAOYSA-N methanesulfonimidic acid Chemical compound CS(N)(=O)=O HNQIVZYLYMDVSB-UHFFFAOYSA-N 0.000 claims 1
- SKTCDJAMAYNROS-UHFFFAOYSA-N methoxycyclopentane Chemical compound COC1CCCC1 SKTCDJAMAYNROS-UHFFFAOYSA-N 0.000 claims 1
- 125000002911 monocyclic heterocycle group Chemical group 0.000 claims 1
- OTYPIDNRISCWQY-UHFFFAOYSA-L palladium(2+);tris(2-methylphenyl)phosphane;dichloride Chemical compound Cl[Pd]Cl.CC1=CC=CC=C1P(C=1C(=CC=CC=1)C)C1=CC=CC=C1C.CC1=CC=CC=C1P(C=1C(=CC=CC=1)C)C1=CC=CC=C1C OTYPIDNRISCWQY-UHFFFAOYSA-L 0.000 claims 1
- LXNAVEXFUKBNMK-UHFFFAOYSA-N palladium(II) acetate Substances [Pd].CC(O)=O.CC(O)=O LXNAVEXFUKBNMK-UHFFFAOYSA-N 0.000 claims 1
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 claims 1
- INIOZDBICVTGEO-UHFFFAOYSA-L palladium(ii) bromide Chemical compound Br[Pd]Br INIOZDBICVTGEO-UHFFFAOYSA-L 0.000 claims 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 claims 1
- JAOLNXGJDXODBO-UHFFFAOYSA-N phosphepane Chemical compound C1CCCPCC1 JAOLNXGJDXODBO-UHFFFAOYSA-N 0.000 claims 1
- GVFQLFXNYFKVCA-UHFFFAOYSA-N phosphinan-4-one Chemical compound O=C1CCPCC1 GVFQLFXNYFKVCA-UHFFFAOYSA-N 0.000 claims 1
- 125000004437 phosphorous atom Chemical group 0.000 claims 1
- 230000010076 replication Effects 0.000 claims 1
- 229960000329 ribavirin Drugs 0.000 claims 1
- HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 claims 1
- 229940124530 sulfonamide Drugs 0.000 claims 1
- 150000003456 sulfonamides Chemical class 0.000 claims 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 claims 1
- 125000000169 tricyclic heterocycle group Chemical group 0.000 claims 1
- WLPUWLXVBWGYMZ-UHFFFAOYSA-N tricyclohexylphosphine Chemical compound C1CCCCC1P(C1CCCCC1)C1CCCCC1 WLPUWLXVBWGYMZ-UHFFFAOYSA-N 0.000 claims 1
- DLQYXUGCCKQSRJ-UHFFFAOYSA-N tris(furan-2-yl)phosphane Chemical compound C1=COC(P(C=2OC=CC=2)C=2OC=CC=2)=C1 DLQYXUGCCKQSRJ-UHFFFAOYSA-N 0.000 claims 1
- UGOMMVLRQDMAQQ-UHFFFAOYSA-N xphos Chemical compound CC(C)C1=CC(C(C)C)=CC(C(C)C)=C1C1=CC=CC=C1P(C1CCCCC1)C1CCCCC1 UGOMMVLRQDMAQQ-UHFFFAOYSA-N 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 125000001475 halogen functional group Chemical group 0.000 description 7
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 6
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 0 CC(C)(C)c1cc(N(C=CC(N2)=O)C2=O)cc(-c(cc2)cc3c2cc(*)cc3)c1OC Chemical compound CC(C)(C)c1cc(N(C=CC(N2)=O)C2=O)cc(-c(cc2)cc3c2cc(*)cc3)c1OC 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- PBISNKVQOXSGFO-UHFFFAOYSA-N 1-tert-butyl-3,5-diiodo-2-methoxybenzene Chemical compound COC1=C(I)C=C(I)C=C1C(C)(C)C PBISNKVQOXSGFO-UHFFFAOYSA-N 0.000 description 1
- 229910017489 Cu I Inorganic materials 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 125000005059 halophenyl group Chemical group 0.000 description 1
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 1
- 229940011051 isopropyl acetate Drugs 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- CMOBXBANKIGTSJ-UHFFFAOYSA-N n-(2-cyanophenyl)pyridine-2-carboxamide Chemical compound C=1C=CC=NC=1C(=O)NC1=CC=CC=C1C#N CMOBXBANKIGTSJ-UHFFFAOYSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36529310P | 2010-07-16 | 2010-07-16 | |
| US61/365,293 | 2010-07-16 | ||
| US201161444475P | 2011-02-18 | 2011-02-18 | |
| US61/444,475 | 2011-02-18 | ||
| PCT/US2011/044283 WO2012009699A2 (en) | 2010-07-16 | 2011-07-15 | Process for preparing antiviral compounds |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015191211A Division JP6162191B2 (ja) | 2010-07-16 | 2015-09-29 | 抗ウイルス性化合物を調製するための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013532636A JP2013532636A (ja) | 2013-08-19 |
| JP2013532636A5 true JP2013532636A5 (enExample) | 2015-09-10 |
| JP5819959B2 JP5819959B2 (ja) | 2015-11-24 |
Family
ID=45467152
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013519865A Expired - Fee Related JP5819959B2 (ja) | 2010-07-16 | 2011-07-15 | 抗ウイルス性化合物を調製するための方法 |
| JP2015191211A Expired - Fee Related JP6162191B2 (ja) | 2010-07-16 | 2015-09-29 | 抗ウイルス性化合物を調製するための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015191211A Expired - Fee Related JP6162191B2 (ja) | 2010-07-16 | 2015-09-29 | 抗ウイルス性化合物を調製するための方法 |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US8895737B2 (enExample) |
| EP (3) | EP2593439B1 (enExample) |
| JP (2) | JP5819959B2 (enExample) |
| KR (1) | KR101893751B1 (enExample) |
| CN (2) | CN105622525B (enExample) |
| AU (1) | AU2011278927B2 (enExample) |
| BR (1) | BR112013001132A2 (enExample) |
| CA (1) | CA2805748A1 (enExample) |
| CL (2) | CL2013000159A1 (enExample) |
| CO (1) | CO6670583A2 (enExample) |
| CR (2) | CR20180412A (enExample) |
| DO (1) | DOP2013000017A (enExample) |
| EA (2) | EA201790723A1 (enExample) |
| EC (1) | ECSP13012438A (enExample) |
| GT (1) | GT201300021A (enExample) |
| IL (1) | IL224222A (enExample) |
| MX (2) | MX2013000623A (enExample) |
| MY (1) | MY167881A (enExample) |
| NZ (2) | NZ705225A (enExample) |
| PE (1) | PE20131086A1 (enExample) |
| PH (1) | PH12013500105A1 (enExample) |
| SG (2) | SG10201505540SA (enExample) |
| UA (1) | UA115025C2 (enExample) |
| WO (1) | WO2012009699A2 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8975443B2 (en) | 2010-07-16 | 2015-03-10 | Abbvie Inc. | Phosphine ligands for catalytic reactions |
| MX2013000623A (es) * | 2010-07-16 | 2013-06-13 | Abbvie Inc | Proceso para la preparación de compuestos antivirales. |
| KR101774742B1 (ko) | 2010-07-16 | 2017-09-11 | 애브비 아일랜드 언리미티드 컴퍼니 | 촉매 반응용 포스핀 리간드 |
| US9255074B2 (en) | 2010-07-16 | 2016-02-09 | Abbvie Inc. | Process for preparing antiviral compounds |
| SG10202010626PA (en) * | 2011-03-31 | 2020-11-27 | Schaefer Konstanze | Perfluorinated compounds for the non-viral transfer of nucleic acids |
| CN104884440A (zh) * | 2012-08-21 | 2015-09-02 | 艾伯维公司 | 用于制备抗病毒化合物的方法 |
| HRP20220911T1 (hr) | 2013-09-11 | 2022-10-28 | Emory University | Sastav nukleotida i nukleozida i njihova uporaba |
| WO2016054240A1 (en) | 2014-09-30 | 2016-04-07 | Sean Dalziel | Fixed dose combinations for the treatment of viral diseases |
| WO2016105547A1 (en) | 2014-12-24 | 2016-06-30 | Concert Pharmaceuticals, Inc. | Deuterated dasabuvir |
| CA3022119A1 (en) | 2016-04-28 | 2017-11-02 | Emory University | Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto |
| WO2017202207A1 (zh) * | 2016-05-27 | 2017-11-30 | 深圳市塔吉瑞生物医药有限公司 | 一种取代的萘环化合物及药物组合物及其应用 |
| CN110201714B (zh) * | 2019-07-04 | 2022-07-29 | 蚌埠学院 | 二氢嘧啶酮类化合物合成方法及催化剂 |
| CN110669006A (zh) * | 2019-10-22 | 2020-01-10 | 中国科学技术大学 | 茚并异喹啉类化合物及其制备方法 |
| CN112735799B (zh) * | 2020-12-10 | 2022-12-20 | 华东理工大学 | 一种新型磁性材料及其制备方法 |
Family Cites Families (89)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4239888A (en) | 1974-11-04 | 1980-12-16 | Pfizer Inc. | 1-Phenyluracils |
| JPS60243017A (ja) | 1984-05-16 | 1985-12-03 | Kyowa Hakko Kogyo Co Ltd | 抗けいれん組成物 |
| US4731472A (en) | 1986-03-03 | 1988-03-15 | Merck & Co., Inc. | (5,6-dichloro-3-oxo-9A-propyl-2,3,9,9A-tetrahydrofluoren-7-yl)alkanoic acids and alkanimidamides |
| US4873238A (en) | 1988-09-19 | 1989-10-10 | American Home Products Corporation | 2-Pyridinecarbothioamides and pharmaceutical compositions comprising the same |
| US4958023A (en) | 1988-09-19 | 1990-09-18 | American Home Products Corporation | 2-pyridinecarbothioamides, processes for preparation thereof and pharmaceutical compositions comprising the same |
| US5084084A (en) | 1989-07-14 | 1992-01-28 | Nissan Chemical Industries Ltd. | Uracil derivatives and herbicides containing the same as active ingredient |
| AU627906B2 (en) | 1989-07-14 | 1992-09-03 | Nissan Chemical Industries Ltd. | Uracil derivatives and herbicides containing the same as active ingredient |
| DE69129998T2 (de) | 1990-02-15 | 1998-12-24 | Takeda Chemical Industries, Ltd., Osaka | Pyrimidindionderivate, deren Herstellung und Verwendung |
| NL9001075A (enExample) | 1990-05-04 | 1991-12-02 | Duphar Int Res | |
| ATE136878T1 (de) | 1990-11-21 | 1996-05-15 | Massachusetts Inst Technology | Neue methoden zur katalytischen reduktion organischer substrate |
| US5489682A (en) | 1990-11-21 | 1996-02-06 | Massachusetts Institute Of Technology | Catalytic asymmetric reduction of enamines |
| DE59308424D1 (de) | 1992-01-31 | 1998-05-28 | Hoffmann La Roche | Diphosphinliganden |
| JPH05213755A (ja) | 1992-02-07 | 1993-08-24 | Nikko Kyodo Co Ltd | 肝臓障害治療薬 |
| JP3345476B2 (ja) | 1993-05-18 | 2002-11-18 | 株式会社東芝 | 有機非線形光学材料 |
| IT1264813B1 (it) | 1993-07-28 | 1996-10-10 | Oxon Italia Spa | Procedimento per la preparazione di alcansolfonammidi |
| DK0647648T3 (da) | 1993-10-08 | 1999-09-27 | Hoffmann La Roche | Optisk aktive phosphorforbindelser |
| DE19528305A1 (de) | 1995-08-02 | 1997-02-06 | Bayer Ag | Substituierte Phenyluracile |
| WO1997018179A1 (en) | 1995-11-14 | 1997-05-22 | Massachusetts Institute Of Technology | Replacement solvents for use in chemical synthesis |
| US6031105A (en) | 1996-04-09 | 2000-02-29 | Pfizer Inc | Substituted pyridines |
| US5847166A (en) | 1996-10-10 | 1998-12-08 | Massachusetts Institute Of Technology | Synthesis of aryl ethers |
| US6242616B1 (en) | 1996-12-03 | 2001-06-05 | The Trustees Of The University Of Pennsylvania | Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives |
| US6096904A (en) | 1996-12-03 | 2000-08-01 | The Trustees Of The University Of Pennsylvania | Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives |
| US20050065353A1 (en) | 1996-12-03 | 2005-03-24 | Smith Amos B. | Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof |
| US5789605A (en) | 1996-12-03 | 1998-08-04 | Trustees Of The University Of Pennsylvania | Synthetic techniques and intermediates for polyhydroxy, dienyl lactones and mimics thereof |
| US6870058B2 (en) | 1996-12-03 | 2005-03-22 | The Trustees Of The University Of Pennsylvania | Compounds which mimic the chemical and biological properties of discodermolide |
| US6323366B1 (en) | 1997-07-29 | 2001-11-27 | Massachusetts Institute Of Technology | Arylamine synthesis |
| WO1999018057A1 (en) | 1997-10-06 | 1999-04-15 | Massachusetts Institute Of Technology | Preparation of diaryl ether by condensation reactions |
| US6867310B1 (en) | 1997-11-20 | 2005-03-15 | Massachusetts Institute Of Technology | Arylation and vinylation of activated carbons |
| WO1999028290A1 (en) | 1997-12-03 | 1999-06-10 | Massachusetts Institute Of Technology | Synthesis of oligoarylamines, and uses and reagents related thereto |
| CA2322194C (en) | 1998-02-26 | 2011-04-26 | Massachusetts Institute Of Technology | Metal-catalyzed arylations and vinylations of hydrazines, hydrazones, hydroxylamines and oximes |
| US7223879B2 (en) | 1998-07-10 | 2007-05-29 | Massachusetts Institute Of Technology | Ligands for metals and improved metal-catalyzed processes based thereon |
| ATE360634T1 (de) | 1998-07-10 | 2007-05-15 | Massachusetts Inst Technology | Ligande für metalle und verbesserte metall- katalysierte verfahren, die darauf basieren |
| US6307087B1 (en) | 1998-07-10 | 2001-10-23 | Massachusetts Institute Of Technology | Ligands for metals and improved metal-catalyzed processes based thereon |
| US6395916B1 (en) | 1998-07-10 | 2002-05-28 | Massachusetts Institute Of Technology | Ligands for metals and improved metal-catalyzed processes based thereon |
| DE19920847A1 (de) | 1999-05-06 | 2000-11-09 | Clariant Gmbh | Pd- und Ni-Komplexe von Biphenyl-2-yl-phosphanen und ihre Anwendung in katalytischen C,C-,N- und C,O-Kupplungen |
| US6465664B1 (en) | 1999-09-15 | 2002-10-15 | Massachusetts Institute Of Technology | Asymmetric 1,4-reductions of and 1,4-additions to enoates and related systems |
| JP2003514913A (ja) | 1999-11-24 | 2003-04-22 | マサチューセッツ インスティテュート オブ テクノロジー | 多糖、天然生成物及びコンビナトリアル・ライブラリの合成に有用な保護基 |
| US6380387B1 (en) | 1999-12-06 | 2002-04-30 | Hoffmann-La Roche Inc. | 4-Pyrimidinyl-n-acyl-l phenylalanines |
| EP1237878B1 (en) | 1999-12-06 | 2007-03-21 | F. Hoffmann-La Roche Ag | 4-pyrimidinyl-n-acyl-l-phenylalanines |
| IL167956A (en) | 2000-02-04 | 2009-02-11 | Sumitomo Chemical Co | Isocyanate compounds |
| MY164523A (en) | 2000-05-23 | 2017-12-29 | Univ Degli Studi Cagliari | Methods and compositions for treating hepatitis c virus |
| US6624159B2 (en) | 2000-07-12 | 2003-09-23 | Pharmacia & Upjohn Company | Heterocycle carboxamides as antiviral agents |
| CA2445159C (en) | 2001-04-24 | 2012-09-11 | Massachusetts Institute Of Technology | Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| EP1409452A1 (en) * | 2001-06-05 | 2004-04-21 | Eli Lilly And Company | Sulfonamide derivatives |
| CA2456553A1 (en) | 2001-08-07 | 2003-02-20 | Amos B. Smith, Iii | Compounds which mimic the chemical and biological properties of discodermolide |
| DE10162700A1 (de) * | 2001-12-19 | 2003-07-03 | Merck Patent Gmbh | Dioxathianone |
| CA2471089A1 (en) | 2001-12-20 | 2003-07-03 | Pharmacia & Upjohn Company | Pyridoquinoxaline antivirals |
| AU2003217232A1 (en) | 2002-02-04 | 2003-09-02 | Massachusetts Institute Of Technology | Transition-metal-catalyzed carbon-nitrogen bond-forming methods using carbene ligands |
| ITMI20020415A1 (it) | 2002-03-01 | 2003-09-01 | Chemi Spa | Catalizzatori metallici per reazione chemo- regio- stereo-selettive erelativi precursori |
| KR20050032107A (ko) | 2002-08-02 | 2005-04-06 | 메사추세츠 인스티튜트 오브 테크놀로지 | 구리를 촉매로 한 탄소-헤테로원자 결합 및 탄소-탄소결합 형성방법 |
| US20040110802A1 (en) | 2002-08-23 | 2004-06-10 | Atli Thorarensen | Antibacterial benzoic acid derivatives |
| US20050113450A1 (en) | 2002-08-23 | 2005-05-26 | Atli Thorarensen | Antibacterial agents |
| AU2003265382A1 (en) | 2002-08-23 | 2004-03-11 | Pharmacia & Upjohn Company Llc | Antibacterial benzoic acid derivatives |
| US7208490B2 (en) | 2002-10-07 | 2007-04-24 | Pharmacia & Upjohn Company Llc | Tricyclic tetrahydroquinoline antibacterial agents |
| US20040097492A1 (en) * | 2002-11-01 | 2004-05-20 | Pratt John K | Anti-infective agents |
| DK2583958T3 (en) | 2002-12-09 | 2016-11-28 | Massachusetts Inst Of Tech (Mit) | LIGANDS OF METALS AND IMPROVED METAL catalyzed processes based thereon |
| US7163937B2 (en) | 2003-08-21 | 2007-01-16 | Bristol-Myers Squibb Company | Cyclic derivatives as modulators of chemokine receptor activity |
| DE60324208D1 (de) | 2003-12-04 | 2008-11-27 | Wyeth Corp | Biarylsulfonamide als mmp-inhibitoren |
| US7507832B2 (en) | 2003-12-22 | 2009-03-24 | Eli Lilly And Company | Triazole PPAR modulators |
| ATE404546T1 (de) | 2004-11-10 | 2008-08-15 | Pfizer | Substituierte n-sulfonylaminobenzyl-2- phenoxyacetamidverbindungen |
| SE0403006D0 (sv) | 2004-12-09 | 2004-12-09 | Biovitrum Ab | New compounds |
| GB0427403D0 (en) | 2004-12-15 | 2005-01-19 | Astrazeneca Ab | Novel compounds I |
| CA2589695A1 (en) | 2004-12-17 | 2006-06-22 | Eli Lilly And Company | Thiazolopyridinone derivates as mch receptor antagonists |
| US7560596B2 (en) | 2005-01-10 | 2009-07-14 | Massachusetts Institute Of Technology | Transition-metal-catalyzed carbon-nitrogen and carbon-carbon bond-forming reactions |
| EP1858865B1 (en) | 2005-03-10 | 2009-09-16 | Pfizer Inc. | Substituted n-sulfonylaminophenylethyl-2-phenoxy acetamide compounds |
| BRPI0608436A2 (pt) | 2005-03-17 | 2009-12-29 | Pfizer | derivados de n-(n-sulfonilaminometil) ciclopropanocarboxamida utilizáveis para o tratamento de dor |
| JP2009536657A (ja) | 2006-05-10 | 2009-10-15 | レノビス， インコーポレイテッド | イオンチャンネルリガンドとしてのアミド誘導体およびそれを用いる医薬組成物および方法 |
| GB0713686D0 (en) | 2007-07-13 | 2007-08-22 | Addex Pharmaceuticals Sa | New compounds 2 |
| US8258131B2 (en) | 2007-08-01 | 2012-09-04 | Mitsubishi Tanabe Pharma Corporation | Fused bicyclic compound |
| WO2009039135A1 (en) | 2007-09-17 | 2009-03-26 | Abbott Laboratories | N-phenyl-dioxo-hydropyrimidines useful as hepatitis c virus (hcv) inhibitors |
| PT2639226T (pt) | 2007-09-17 | 2016-12-09 | Abbvie Bahamas Ltd | Pirimidinas anti-infeciosas e suas utilizações |
| JP5734654B2 (ja) | 2007-09-17 | 2015-06-17 | アッヴィ・バハマズ・リミテッド | Ｃ型肝炎を治療するためのウラシルまたはチミン誘導体 |
| CA2708369C (en) | 2007-12-12 | 2017-04-04 | Massachusetts Institute Of Technology | Ligands for transition-metal-catalyzed cross-couplings, and methods of use thereof |
| ES2383273T3 (es) | 2008-07-23 | 2012-06-19 | F. Hoffmann-La Roche Ag | Compuestos heterocíclicos antivíricos |
| EP2184273A1 (de) | 2008-11-05 | 2010-05-12 | Bayer CropScience AG | Halogen-substituierte Verbindungen als Pestizide |
| JP5326510B2 (ja) | 2008-11-11 | 2013-10-30 | セントラル硝子株式会社 | α−置換エステル類の製造方法 |
| MY169288A (en) | 2009-03-24 | 2019-03-21 | Abbott Lab | Process for preparing an antiviral compound |
| BRPI1011744A2 (pt) | 2009-06-24 | 2016-03-22 | Hoffmann La Roche | composto antiviral heterocíclico. |
| US20110005533A1 (en) | 2009-07-07 | 2011-01-13 | Evans Douglas J | Mold For a Smoking Device |
| WO2011008725A2 (en) | 2009-07-13 | 2011-01-20 | Massachusetts Institute Of Technology | Metal-catalyzed carbon-fluorine bond formation |
| WO2011008618A1 (en) | 2009-07-13 | 2011-01-20 | National University Of Singapore | Metal-catalyzed carbon-fluorine bond formation |
| AR079170A1 (es) | 2009-12-10 | 2011-12-28 | Lilly Co Eli | Compuesto de ciclopropil-benzamida-imidazo-benzazepina inhibidor de diacil-glicerol aciltransferasa, sal del mismo, composicion farmaceutica que lo comprende, su uso para preparar un medicamento util para el tratamiento de obesidad o para mejorar la sensibilidad a insulina y compuesto intermedio par |
| EP2521724B1 (en) | 2009-12-11 | 2016-11-23 | Nono Inc. | Agents and methods for treating ischemic and other diseases |
| WO2011082400A2 (en) | 2010-01-04 | 2011-07-07 | President And Fellows Of Harvard College | Modulators of immunoinhibitory receptor pd-1, and methods of use thereof |
| FR2958289B1 (fr) | 2010-03-30 | 2012-06-15 | Sanofi Aventis | Procede de preparation de derives de 3-ceto-benzofurane |
| WO2011133795A2 (en) | 2010-04-22 | 2011-10-27 | The Brigham And Women's Hospital, Inc. | Beta-carbolines as inhibitors of haspin and dyrk kinases |
| US8980929B2 (en) | 2010-05-21 | 2015-03-17 | Merck Sharp & Dohme Corp. | Substituted seven-membered heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes |
| MX2013000623A (es) * | 2010-07-16 | 2013-06-13 | Abbvie Inc | Proceso para la preparación de compuestos antivirales. |
| KR101774742B1 (ko) | 2010-07-16 | 2017-09-11 | 애브비 아일랜드 언리미티드 컴퍼니 | 촉매 반응용 포스핀 리간드 |
-
2011
- 2011-07-15 MX MX2013000623A patent/MX2013000623A/es active IP Right Grant
- 2011-07-15 AU AU2011278927A patent/AU2011278927B2/en not_active Ceased
- 2011-07-15 NZ NZ705225A patent/NZ705225A/en not_active IP Right Cessation
- 2011-07-15 CN CN201610048270.9A patent/CN105622525B/zh not_active Expired - Fee Related
- 2011-07-15 US US13/184,440 patent/US8895737B2/en not_active Expired - Fee Related
- 2011-07-15 NZ NZ605767A patent/NZ605767A/en not_active IP Right Cessation
- 2011-07-15 EP EP11739236.5A patent/EP2593439B1/en active Active
- 2011-07-15 CA CA2805748A patent/CA2805748A1/en not_active Abandoned
- 2011-07-15 MY MYPI2013700083A patent/MY167881A/en unknown
- 2011-07-15 SG SG10201505540SA patent/SG10201505540SA/en unknown
- 2011-07-15 SG SG2013003579A patent/SG187102A1/en unknown
- 2011-07-15 CR CR20180412A patent/CR20180412A/es unknown
- 2011-07-15 UA UAA201301879A patent/UA115025C2/uk unknown
- 2011-07-15 WO PCT/US2011/044283 patent/WO2012009699A2/en not_active Ceased
- 2011-07-15 PH PH1/2013/500105A patent/PH12013500105A1/en unknown
- 2011-07-15 EP EP18182779.1A patent/EP3415504A1/en not_active Withdrawn
- 2011-07-15 PE PE2013000078A patent/PE20131086A1/es not_active Application Discontinuation
- 2011-07-15 EP EP16158981.7A patent/EP3056486B1/en not_active Not-in-force
- 2011-07-15 EA EA201790723A patent/EA201790723A1/ru unknown
- 2011-07-15 MX MX2015002113A patent/MX344148B/es unknown
- 2011-07-15 KR KR1020137003947A patent/KR101893751B1/ko not_active Expired - Fee Related
- 2011-07-15 EA EA201390130A patent/EA028082B1/ru not_active IP Right Cessation
- 2011-07-15 JP JP2013519865A patent/JP5819959B2/ja not_active Expired - Fee Related
- 2011-07-15 CN CN201180044545.7A patent/CN103097360B/zh not_active Expired - Fee Related
- 2011-07-15 BR BR112013001132A patent/BR112013001132A2/pt not_active Application Discontinuation
-
2013
- 2013-01-14 IL IL224222A patent/IL224222A/en active IP Right Grant
- 2013-01-16 DO DO2013000017A patent/DOP2013000017A/es unknown
- 2013-01-16 CL CL2013000159A patent/CL2013000159A1/es unknown
- 2013-01-16 GT GT201300021A patent/GT201300021A/es unknown
- 2013-02-07 CO CO13025305A patent/CO6670583A2/es unknown
- 2013-02-08 CR CR20130054A patent/CR20130054A/es unknown
- 2013-02-13 EC ECSP13012438 patent/ECSP13012438A/es unknown
-
2015
- 2015-09-29 JP JP2015191211A patent/JP6162191B2/ja not_active Expired - Fee Related
-
2016
- 2016-02-19 CL CL2016000382A patent/CL2016000382A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013532636A5 (enExample) | ||
| Fu et al. | Palladium-catalyzed air-based oxidative coupling of arylboronic acids with H-phosphine oxides leading to aryl phosphine oxides | |
| KR101893751B1 (ko) | 항바이러스성 화합물의 제조 방법 | |
| JP5803042B2 (ja) | クロスカップリング反応におけるモノリン配位子及びそれらの使用 | |
| TWI663155B (zh) | 製造嘧啶磺醯胺衍生物之方法 | |
| TWI634108B (zh) | 嘧啶中間物之製備 | |
| JP6800334B2 (ja) | Ｂｔｋ阻害剤を調製するプロセス | |
| CN104926811B (zh) | 3-氰基咪唑并[1,2-a]吡啶化合物的合成方法及其应用 | |
| KR20070092307A (ko) | 로수바스타틴 제조 방법 | |
| KR102472711B1 (ko) | 트리아진, 피리미딘 및 피리딘 유도체의 신규한 제조방법 | |
| CN107250141A (zh) | 磷配体及使用方法 | |
| JP2018525391A (ja) | 芳香族またはビニル系化合物をホウ素含有化合物にカップリングさせるための方法 | |
| CN104884440A (zh) | 用于制备抗病毒化合物的方法 | |
| JP2017105717A (ja) | カップリング反応副生物の低減方法 | |
| CN108586519A (zh) | 一种有机硅烷或有机锗烷衍生物的制备方法 | |
| JP2017531635A (ja) | フルオロスルホネート化合物をアミン化合物にカップリングさせるための方法 | |
| TWI618729B (zh) | 聚芳基聚合物之形成方法及由此形成之聚合物 | |
| CN105294573B (zh) | 一种合成4,6-二氯-2-(丙硫基)-5-氨基嘧啶的方法 | |
| EP3484842B1 (en) | Halogen-containing metathesis catalysts and methods thereof | |
| CN103242378A (zh) | 二茂铁基嘧啶钳形配体及其制备方法 | |
| JP2021066737A (ja) | カップリング化合物の製造方法 | |
| EP3237383B1 (en) | One-step process for the synthesis of alkylated metyrapone analogs | |
| JP6837883B2 (ja) | ジシアノアリール若しくはジシアノヘテロアリールの電子供与性基の二置換体の製造方法 | |
| CN104619683A (zh) | 用于制备任选地取代的苯基和吡啶基吡咯烷类的方法 | |
| CN115160315A (zh) | 7-氮杂吲哚类衍生物及其制备方法 |